General
Oxford-AstraZeneca COVID-19 vaccine has been authorised in the UK. Here’s why this is a key moment
The UK has become the first country to authorise the Oxford-AstraZeneca COVID-19 vaccine for public use, with roll-out to start in the first week of 2021. This vaccine is the second to be authorised in the UK — following the Pfizer-BioNTech vaccine.
The British Government has ordered 100 million doses of the Oxford vaccine, enough to vaccinate 50 million people. Other countries will be watching closely: Australia has ordered over 50 million doses, Canada 20 million, and worldwide over 2.5 billion doses have been pre-ordered.
AstraZeneca expects to be able to supply large numbers of doses within the first quarter of 2021.
-
Business10 hours agoDicker Data rides the AI trend to double digit growth
-
Business14 hours agoThis ASX 200 healthcare stock crashed 14% to 4-year low. Here’s what happened
-
Business18 hours agoThis leading broker thinks the CSL share price can climb 40%
-
General23 hours agoDenmark summons US envoy over suspected influence operations in Greenland